NO2231189T3 - - Google Patents

Info

Publication number
NO2231189T3
NO2231189T3 NO08861526A NO08861526A NO2231189T3 NO 2231189 T3 NO2231189 T3 NO 2231189T3 NO 08861526 A NO08861526 A NO 08861526A NO 08861526 A NO08861526 A NO 08861526A NO 2231189 T3 NO2231189 T3 NO 2231189T3
Authority
NO
Norway
Application number
NO08861526A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2231189(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2231189T3 publication Critical patent/NO2231189T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO08861526A 2007-12-19 2008-12-18 NO2231189T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/SE2007/001127 WO2009078754A1 (en) 2007-12-19 2007-12-19 Drug delivery system for administration of poorly water soluble pharmaceutically active substances
PCT/SE2008/051515 WO2009078802A1 (en) 2007-12-19 2008-12-18 Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (1)

Publication Number Publication Date
NO2231189T3 true NO2231189T3 (https=) 2018-02-03

Family

ID=40795732

Family Applications (2)

Application Number Title Priority Date Filing Date
NO08861526A NO2231189T3 (https=) 2007-12-19 2008-12-18
NO2019023C NO2019023I1 (no) 2007-12-19 2019-05-08 Paclitaxel micellar

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2019023C NO2019023I1 (no) 2007-12-19 2019-05-08 Paclitaxel micellar

Country Status (27)

Country Link
US (4) US8999382B2 (https=)
EP (1) EP2231189B1 (https=)
JP (1) JP5466172B2 (https=)
KR (1) KR101572703B1 (https=)
CN (1) CN101951956B (https=)
AU (1) AU2008339099B2 (https=)
BR (1) BRPI0821740B1 (https=)
CA (1) CA2709266C (https=)
CY (2) CY1119805T1 (https=)
DK (1) DK2231189T3 (https=)
EA (1) EA015247B1 (https=)
ES (1) ES2650242T3 (https=)
FR (1) FR19C1030I1 (https=)
HR (1) HRP20171796T1 (https=)
HU (1) HUE034684T2 (https=)
LT (2) LT2231189T (https=)
LU (1) LUC00117I2 (https=)
MX (1) MX2010006914A (https=)
MY (2) MY157186A (https=)
NL (1) NL300987I9 (https=)
NO (2) NO2231189T3 (https=)
NZ (1) NZ586859A (https=)
PL (1) PL2231189T3 (https=)
PT (1) PT2231189T (https=)
SI (1) SI2231189T1 (https=)
WO (2) WO2009078754A1 (https=)
ZA (1) ZA201004685B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
JP2012524780A (ja) * 2009-04-21 2012-10-18 セレクタ バイオサイエンシーズ インコーポレーテッド Ｔｈ１バイアス応答をもたらす免疫ナノ治療薬（Ｉｍｍｕｎｏｎａｎｏｔｈｅｒａｐｅｕｔｉｃｓ）
CA2798739A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Nanocarrier compositions with uncoupled adjuvant
EA201390660A1 (ru) 2010-11-05 2013-11-29 Селекта Байосайенсиз, Инк. Модифицированные никотиновые соединения и связанные способы
CN103908432B (zh) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112321465B (zh) 2019-07-18 2023-06-06 上海现代药物制剂工程研究中心有限公司 一种含苯基化合物、其中间体、制备方法及应用
CN112239418B (zh) * 2019-07-18 2023-07-07 上海现代药物制剂工程研究中心有限公司 视黄醇类化合物及其钠盐的制备方法
WO2021259472A1 (en) * 2020-06-24 2021-12-30 Oasmia Pharmaceutical Ab Micellar docetaxel for use in the treatment of cancer
CN115429886B (zh) * 2021-06-02 2025-10-31 复旦大学 一种药物纳米结晶制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) * 1998-12-23 2001-03-06 Ardenia Investments Ltd. Compounds for the treatment of cancer
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
SE0202311D0 (sv) * 2002-07-23 2002-07-23 Ardenia Investments Ltd Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
AU2002347747A1 (en) * 2002-07-23 2004-02-09 Ardenia Investments Ltd. Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents
US7259984B2 (en) * 2002-11-26 2007-08-21 Cornell Research Foundation, Inc. Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja) 2003-09-04 2006-08-03 Nano Career Kk 水溶性の塩基性薬物内包ナノ粒子含有組成物
WO2005089106A2 (en) 2004-02-27 2005-09-29 Molecular Therapeutics, Inc. Degradable nanoparticles
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
WO2007001356A2 (en) * 2004-09-10 2007-01-04 University Of Wyoming Nanoparticles for cytoplasmic drug delivery to cancer cells
EP3527202A1 (en) * 2005-08-31 2019-08-21 Abraxis BioScience, LLC Compositions and methods for preparation of poorly water soluble drugs with increased stability
WO2009078755A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Also Published As

Publication number Publication date
USRE49742E1 (en) 2023-12-05
CN101951956A (zh) 2011-01-19
LT2231189T (lt) 2017-12-27
EA200802350A3 (ru) 2009-10-30
WO2009078754A1 (en) 2009-06-25
US8999382B2 (en) 2015-04-07
WO2009078802A1 (en) 2009-06-25
FR19C1030I1 (fr) 2019-06-21
ES2650242T3 (es) 2018-01-17
CY2019021I1 (el) 2019-11-27
EA015247B1 (ru) 2011-06-30
EP2231189A1 (en) 2010-09-29
SI2231189T1 (en) 2018-03-30
HRP20171796T1 (hr) 2018-01-26
EA200802350A2 (ru) 2009-06-30
LTPA2019508I1 (lt) 2019-05-10
NL300987I2 (https=) 2019-05-09
US20110014281A1 (en) 2011-01-20
USRE49741E1 (en) 2023-12-05
CY2019021I2 (el) 2019-11-27
AU2008339099A1 (en) 2009-06-25
US9993438B2 (en) 2018-06-12
NZ586859A (en) 2012-06-29
HUE034684T2 (en) 2018-02-28
CA2709266C (en) 2017-09-26
CA2709266A1 (en) 2009-06-25
KR101572703B1 (ko) 2015-11-27
MY157187A (en) 2016-05-13
PL2231189T3 (pl) 2018-03-30
NO2019023I1 (no) 2019-05-08
AU2008339099B2 (en) 2015-08-13
LUC00117I2 (https=) 2024-05-22
MX2010006914A (es) 2010-11-10
MY157186A (en) 2016-05-13
EP2231189A4 (en) 2013-10-09
CY1119805T1 (el) 2018-06-27
NL300987I9 (nl) 2019-05-16
BRPI0821740A2 (pt) 2020-02-27
JP5466172B2 (ja) 2014-04-09
ZA201004685B (en) 2011-03-30
CN101951956B (zh) 2012-10-17
DK2231189T3 (en) 2017-12-11
US20150164819A1 (en) 2015-06-18
JP2011507838A (ja) 2011-03-10
BRPI0821740B1 (pt) 2021-05-18
PT2231189T (pt) 2017-12-12
KR20100094575A (ko) 2010-08-26
EP2231189B1 (en) 2017-09-06

Similar Documents

Publication Publication Date Title
NL300987I2 (https=)
CN300785195S (zh) 印花纸(07-2)
CN300874238S (zh) 标签纸
CN300728410S (zh) 横插灯(方头)
CN300728307S (zh) 型材(pm5786)
CN300728298S (zh) 型材(ymgr5313)
CN300728290S (zh) 型材(f60隔热平开窗边框)
CN300728248S (zh) 加湿器（x120-1）
CN300728094S (zh) 儿童电动车车体
CN300729505S (zh) 包装盒(彩图)
CN300728091S (zh) 玩具直升机螺旋桨平衡杆(1)
CN300728086S (zh) 玩具四驱车(巨浪凶鲨)
CN300727777S (zh) 数控雕铣机床
CN300755668S (zh) 编织帘片材(06lhf-1by)
CN300727410S (zh) 汽车用后门
CN300867142S (zh) 包装盒(2)
CN300861568S (zh) 装饰摆件(虎头)
CN300727346S (zh) 摩托车覆盖件(71)
CN300854821S (zh) 枕套(d-13)
CN300847568S (zh) 托盘(p31)
CN300827576S (zh) 工艺品(木制摩托车a)
CN300727209S (zh) 手表（pmp）
CN300729735S (zh) 花瓶(高杯)
CN300728412S (zh) 吸顶灯(9)
CN300776871S (zh) 服装(19)